LONDON, Jan. 18, 2025 /PRNewswire/ –Kantar Group, a leading, global market research company based in London and portfolio company of Bain Capital, has announced today the proposed sale of Kantar Media to H.I.G. Capital, a leading global alternative investment firm with $67 billion of capital under management. The contemplated deal will mark a new chapter… Continue reading Kantar Group announces the proposed sale of Kantar Media
Tag: Morgan
Data Center General Construction Market, 31% of Growth to Originate from North America, Technavio
NEW YORK, Jan. 17, 2025 /PRNewswire/ — The global data center general construction market size is estimated to grow by USD 19.95 billion from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 10.39% during the forecast period. For comprehensive forecast and historic data on regions,market segments, customer landscape, and… Continue reading Data Center General Construction Market, 31% of Growth to Originate from North America, Technavio
Hugel vows to become global leader at J.P. Morgan Healthcare Conference
– Hugel CFO Eva Huang presents mid- to long-term growth strategy at the APAC Track – The medical aesthetics company aims to expand its presence in more than 80 toxin markets, 70 dermal filler markets, and more than 10 cosmetics markets by 2028 SAN FRANCISCO, Jan. 16, 2025 /PRNewswire/ — Hugel Inc., a leading global… Continue reading Hugel vows to become global leader at J.P. Morgan Healthcare Conference
LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference
New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on “Advancing as a Global CDMO Leader” Unveiling of Next-Generation ADC Platform ‘SoluFlex Link’: Enabling High-Potency, High-Yield ADC Development and Manufacturing Incheon Songdo Bio Campus Plant 1 Under Construction, Targeting Commercial Production by 2027 SEOUL, South Korea, Jan. 16, 2025 /PRNewswire/ — LOTTE… Continue reading LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference
J.F. Lehman & Company Announces Promotions and Team Additions
NEW YORK, Jan. 15, 2025 /PRNewswire/ — J.F. Lehman & Company (“JFLCO”), a leading middle-market private investment firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several promotions and team additions. Promotions include Karina Perelmuter to Managing Director, Megan E. Kanefsky to Director, Bridget A. Harding to Vice… Continue reading J.F. Lehman & Company Announces Promotions and Team Additions
Depo-Provera Brain Tumor Litigation: All-Female Legal Team Takes on Devastating Female Health Issue
MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ — National personal injury law firm Pritzker Hageman has assembled an all-female legal team to pursue litigation on behalf of women who developed meningioma tumors after using Depo-Provera birth control injections. Attorneys Alicia Penner and Morgan Vanden Heuvel are currently representing a South Dakota woman who developed multiple meningiomas following years of receiving Depo-Provera injections. Penner… Continue reading Depo-Provera Brain Tumor Litigation: All-Female Legal Team Takes on Devastating Female Health Issue
J.F. Lehman & Company Announces Promotions and Team Additions
NEW YORK, Jan. 15, 2025 /PRNewswire/ — J.F. Lehman & Company (“JFLCO”), a leading middle-market private investment firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several promotions and team additions. Promotions include Karina Perelmuter to Managing Director, Megan E. Kanefsky to Director, Bridget A. Harding to Vice… Continue reading J.F. Lehman & Company Announces Promotions and Team Additions
Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
Celltrion unveils strategic roadmap for the first time outlining its innovative drug development strategy and its plan to submit 13 Investigational New Drug (IND) application by 2028 Company reinforces its commitment to a two-pillar growth strategy focusing on its groundbreaking new drug developments including next-generation antibody drug conjugates (ADCs) and multispecific antibodies INCHEON, South Korea,… Continue reading Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
Two ENA-backed Studies Featured in January Journal of Emergency Nursing
Journal kicks off 50th year with articles focusing on triage, ENP competencies SCHAUMBURG, Ill., Jan. 14, 2025 /PRNewswire/ — The Journal of Emergency Nursing celebrates 50 years of providing innovative research related to the emergency nursing specialty in 2025, and the first issue of the year features two ENA-driven backed research studies on key topics… Continue reading Two ENA-backed Studies Featured in January Journal of Emergency Nursing
Nayya bolsters leadership bench: George Michaels joins as Chief Revenue Officer and Rabia Qari joins as Chief Consumer Officer
New leaders to drive revenue growth and consumer innovation in health and wealth. NEW YORK, Jan. 14, 2025 /PRNewswire/ — Nayya, a leader in AI-driven benefits personalization and engagement, today announced the addition of two key executives to its leadership team: George Michaels as Chief Revenue Officer (CRO) and Rabia Qari as Chief Consumer Officer (CCO).… Continue reading Nayya bolsters leadership bench: George Michaels joins as Chief Revenue Officer and Rabia Qari joins as Chief Consumer Officer